Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html

Study Counts

Type Study_count
Total_Studies 160
interventional 114
Observational 41
Registry 5

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 28
Drug|placebo 21
Procedure 19
Device 17
Other 8
Behavioral 6
Device|Drug 2
Device|Drug|Procedure 2
Diagnostic Test 2
Behavioral|Drug 1
Behavioral|Drug|Other 1
Biological 1
Combination Product 1
Device|Procedure 1
Diagnostic Test|Drug 1
Dietary Supplement 1
Dietary Supplement|placebo 1
Drug|Procedure 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 36
NA 12
Korea, Republic of 8
Taiwan 8
Italy 5
Canada 4
Denmark 4
Turkey 4
Spain 3
United Kingdom 3
China 2
Netherlands 2
Australia 1
Australia|Belgium|Canada|Chile|Colombia|Denmark|Finland|Greece|Italy|Latvia|Lithuania|Poland|Slovakia|Spain|United Kingdom 1
Australia|New Zealand 1
Austria|Belarus|Belgium|Czechia|France|Germany|Italy|Netherlands|Poland|Slovakia|United Kingdom 1
Austria|Czech Republic|Denmark|Finland|France|Germany|Hungary|Netherlands|Norway|Poland|Portugal|Russian Federation|Slovakia|Spain|Sweden|United Kingdom 1
Czech Republic|Netherlands|Slovakia 1
Egypt 1
Germany|Austria|Belarus|Belgium|Czech Republic|France|Hungary|Italy|Netherlands|Poland|Russian Federation|Slovakia|United Kingdom 1
Hong Kong 1
India 1
Japan 1
Pakistan 1
Portugal 1
Spain|United States|Canada|Czechia|France|Germany|Italy|Poland|United Kingdom 1
Switzerland 1
Thailand 1
United States|Australia 1
United States|Australia|Canada|New Zealand|Russian Federation|Ukraine 1
United States|Belgium|Canada|Czech Republic|Italy|Poland 1
United States|Belgium|Czech Republic|Germany|Hungary|Poland 1
United States|Canada 1
United States|France|Italy|United Kingdom 1
United States|Netherlands|Poland|United Kingdom 1

Sites per Study

Site_count Study_Count
1 79
2 7
3 2
4 3
5 1
6 1
8 1
10 1
11 1
13 1
14 1
15 3
17 1
18 1
27 1
33 1
41 1
46 1
47 1
70 1
76 1
79 1
95 1
98 1
118 1

Phase

Phase Study_Count
N/A 52
Phase 4 20
Phase 2 18
Phase 3 12
Phase 1 4
Phase 1/Phase 2 4
Phase 2/Phase 3 4

Number of Arms

Number_of_Arms Count_of_Studies
1 32
2 58
3 13
4 4
5 1
8 1
NA 5

Enrollment Metrics by Phase

Measure N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 9.0000 12 25.00 7.0000 76.0 74.0000 10.00
1st Qu. 30.7500 18 36.25 63.5000 118.0 177.0000 75.25
Median 62.5000 33 45.00 211.0000 168.0 322.0000 109.00
Mean 110.1731 33 41.25 291.4444 171.5 458.8333 199.95
3rd Qu. 100.0000 48 50.00 455.7500 221.5 554.2500 146.25
Max. 820.0000 54 50.00 919.0000 274.0 1334.0000 1000.00

Trial Group Type

group_type Group_Count
Experimental 105
Active Comparator 59
Placebo Comparator 32
No Intervention 13
Other 6
NA 5
Sham Comparator 1

Intervention Model

intervention_model Study_Count
Parallel Assignment 69
Single Group Assignment 36
Crossover Assignment 9

Primary Purpose

primary_purpose Study_Count
Treatment 89
Diagnostic 9
Supportive Care 5
Basic Science 4
Prevention 4
Health Services Research 1
Other 1
NA 1

Observational Studies

Studies by Country

Country Study_Count
United States 10
France 8
NA 6
Taiwan 5
Poland 2
Turkey 2
Belgium 1
China 1
Czech Republic 1
Greece|Italy|Portugal|Spain|Turkey 1
Ireland 1
Korea, Republic of 1
Poland|Ukraine 1
Portugal|Spain 1

Sites per Study

Site_count Study_Count
1 34
5 2
6 2
8 1
32 1
143 1

Enrollment Metrics

Measure Observational
Min 11.000
1st Qu 34.000
Median 150.000
Mean 1361.902
3rd Qu 729.000
Max 11500.000

Observation Model

observational_model Study_Count
Cohort 26
Other 5
Case-Control 4
Case-Only 4
Case-Crossover 1
NA 1

Time Perspective

time_perspective Study_Count
Prospective 30
Cross-Sectional 5
Retrospective 4
Other 2

Registries

Studies by Country

Country Study_Count
NA 1
Spain 1
Switzerland 1
Taiwan 1
United Kingdom 1

Sites per Study

Site_count Study_Count
1 4
17 1

Enrollment Metrics

Measure Registries
Min 150.0
1st Qu 186.0
Median 318.0
Mean 296.8
3rd Qu 330.0
Max 500.0

Registry Model

observational_model Study_Count
Case-Control 2
Cohort 2
Case-Only 1

Time Perspective

time_perspective Study_Count
Prospective 4
Other 1

Follow-up

target_duration Study_Count
1 Month 1
12 Months 1
12 Weeks 1
12 Years 1
5 Years 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT03337048 Exploratory Study Investigating Urodynamic Parameters During Catheterisation https://ClinicalTrials.gov/show/NCT03337048 Completed Coloplast A/S 2018-05-29
NCT03249987 Comparing the Usability of an Electronic Bladder Diary and a Paper Bladder Diary https://ClinicalTrials.gov/show/NCT03249987 Completed Sheffield Teaching Hospitals NHS Foundation Trust 2018-04-30
NCT03239652 Taiwan ACE Beads for Embolization Therapy in Symptomatic Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT03239652 Recruiting National Cheng-Kung University Hospital 2020-06-30
NCT03230721 ThuLEP vs. HoLEP vs. Monopolar Enucleation in Management of BPH https://ClinicalTrials.gov/show/NCT03230721 Completed I.M. Sechenov First Moscow State Medical University 2017-04-22
NCT03104907 Prostatic Artery Embolization for Obstructive Uropathy Due to Prostate Cancer https://ClinicalTrials.gov/show/NCT03104907 Completed Rigshospitalet, Denmark 2018-11-27
NCT03099421 Prostatic Artery Embolization for Benign Prostatic Obstruction https://ClinicalTrials.gov/show/NCT03099421 Completed Rigshospitalet, Denmark 2018-12-14
NCT02972268 Clinical Trial to Compare the Solifenacin/Tamsulosin Combination Therapy With Tamsulosin Monotherapy for LUTS Due to BPH https://ClinicalTrials.gov/show/NCT02972268 Completed Jeil Pharmaceutical Co., Ltd. 2017-11-02
NCT02930889 Prostate Artery Embolization (PAE) for Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH) https://ClinicalTrials.gov/show/NCT02930889 Recruiting University of Minnesota 2020-10-31
NCT02758938 Urological Biofeedback Game Software https://ClinicalTrials.gov/show/NCT02758938 Completed University of Wisconsin, Madison 2018-01-31
NCT02757768 A Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Men With OAB Symptoms While Taking Tamsulosin Hydrochloride for Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH) https://ClinicalTrials.gov/show/NCT02757768 Completed Astellas Pharma Inc 2018-08-14
NCT02748356 Impact of Probiotics on Urinary Symptoms in Spinal Cord Injury SCI and SB https://ClinicalTrials.gov/show/NCT02748356 Completed Medstar Health Research Institute 2018-10-21
NCT02748317 Impact of Probiotics on Urinary Symptoms in Spinal Cord Injury SCI and SB https://ClinicalTrials.gov/show/NCT02748317 Completed Medstar Health Research Institute 2018-10-31
NCT02742389 Urodynamic Testing: Can we Improve Patient Experience? https://ClinicalTrials.gov/show/NCT02742389 Completed Boston Urogynecology Associates 2017-06-30
NCT02715024 Study to Evaluate the Clinical Efficacy and Safety of Tamsulosin Alone or in Combination With Solifenacin for the Treatment in Men With Lower Urinary Tract Symptoms Including Overactive Bladder Symptoms https://ClinicalTrials.gov/show/NCT02715024 Completed Astellas Pharma Inc 2011-04-30
NCT02676544 Prostate Embolization for Massive Benign Prostatic Hypertrophy (BPH) https://ClinicalTrials.gov/show/NCT02676544 Recruiting Rhode Island Hospital 2020-12-31
NCT02673944 Portable Pves Study https://ClinicalTrials.gov/show/NCT02673944 Completed Laborie Medical Technologies Inc. 2016-03-31
NCT02634489 EC905 Pharmacokinetic Profile Study https://ClinicalTrials.gov/show/NCT02634489 Completed Astellas Pharma Inc 2009-07-31
NCT02592473 Prostate Artery Embolization (PAE) for Treatment of Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT02592473 Recruiting University of Virginia 2021-11-30
NCT02554201 Efficacy of Electrical Pudendal Nerve Stimulation for Neurogenic Lower Urinary Tract Dysfunction https://ClinicalTrials.gov/show/NCT02554201 Completed Shanghai Institute of Acupuncture, Moxibustion and Meridian 2016-10-31
NCT02494349 The PK Study of the JLP-1207 and Solifenacin/Tamsulosin in Healthy Male Volunteers. https://ClinicalTrials.gov/show/NCT02494349 Completed Jeil Pharmaceutical Co., Ltd. 2015-11-30
NCT02462837 Myrbetriqâ„¢ (Mirabegron) to Reduce Pain and Discomfort Following Ureteral Stent Placement https://ClinicalTrials.gov/show/NCT02462837 Completed Southern Illinois University 2019-01-30
NCT02366975 TRT on BPH Hypoganadal MetS Patients. Florence-PROTEST https://ClinicalTrials.gov/show/NCT02366975 Completed University of Florence 2017-01-31
NCT02332538 HoLEP vs. Greenlight 532nm-laser PVEP vs. Bipolar TURP in Management of Moderate/ Large BPH https://ClinicalTrials.gov/show/NCT02332538 Completed Mansoura University 2016-07-31
NCT02330107 Auriculotherapy on Lower Urinary Tract Symptoms in Elderly Men https://ClinicalTrials.gov/show/NCT02330107 Completed The Hong Kong Polytechnic University 2017-06-30
NCT02326454 A Placebo Controlled Study of MR901 (Talaporfin Sodium Sodium + a Drug-activating Device) for the Relief of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT02326454 Completed Light Sciences Oncology 2017-03-29
NCT02291432 Autologous Cell Therapy for Stress Urinary Incontinence in Males Following Prostate Surgery https://ClinicalTrials.gov/show/NCT02291432 Completed Cook MyoSite 2019-06-28
NCT02272309 Neurophysiological Assessment of Healthy and Impaired Human Lower Urinary Tract Function https://ClinicalTrials.gov/show/NCT02272309 Recruiting University of Zurich 2023-12-31
NCT02271607 The Effect and Safety of Moxibustion Therapy for Overactive Bladder Patients https://ClinicalTrials.gov/show/NCT02271607 Completed Korean Medicine Hospital of Pusan National University 2015-12-31
NCT02252367 Effect of 12 Weeks Treatment With Tadalafil vs Placebo on Lower Urinary Tract Symptoms https://ClinicalTrials.gov/show/NCT02252367 Active, not recruiting University of Florence 2019-01-31
NCT02245490 Study to Characterise the Effect of Tamsulosin on Lower Urinary Tract Symptoms (LUTS) and Detrusor Motor Activity in Patients Affected by Benign Prostatic Hyperplasia (BPH) and Storage Urinary Symptoms https://ClinicalTrials.gov/show/NCT02245490 Completed Boehringer Ingelheim 2004-04-30
NCT02244281 Study of FLOMAX® Versus Placebo in Female Patients With Lower Urinary Tract Symptoms (LUTS) With a Significant Component of Voiding Symptoms https://ClinicalTrials.gov/show/NCT02244281 Completed Boehringer Ingelheim 2003-11-30
NCT02193451 Urodynamics for Prostate Surgery Trial; Randomised Evaluation of Assessment Methods https://ClinicalTrials.gov/show/NCT02193451 Active, not recruiting North Bristol NHS Trust 2018-07-31
NCT02074644 Clinical Trial of Prostatic Arterial Embolization Versus a Sham Procedure to Treat Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT02074644 Completed Hospital St. Louis, Lisbon, Portugal 2019-03-03
NCT01282840 Bladder Wall Blood Perfusion Pattern and Sexual Dysfunction in Female Patients With Lower Urinary Tract Symptoms, and the Association of That Perfusion Pattern and Therapeutic Efficacy of Antimuscarincs for Female Overactive Bladder Syndrome. https://ClinicalTrials.gov/show/NCT01282840 Completed Far Eastern Memorial Hospital 2018-11-05
NCT02051036 Moxibustion as an Adjuvant for Benign Prostatic Hyperplasia With Lower Urinary Tract Symptoms: a Pilot Study https://ClinicalTrials.gov/show/NCT02051036 Completed Korean Medicine Hospital of Pusan National University 2015-12-31
NCT01963312 Clinical Trial to Evaluate the Efficacy and Safety of the Transarterial Supraselective Embolization of the Prostate to Treat the Urinary Symptoms. https://ClinicalTrials.gov/show/NCT01963312 Completed Fundacion Miguel Servet 2018-04-30
NCT01939756 Intravesical Natural Baobab Oil in the Management of BCG-induced Lower Urinary Tract Symptoms https://ClinicalTrials.gov/show/NCT01939756 Completed University of Rome Tor Vergata 2013-06-30
NCT01939184 Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT01939184 Completed Warner Chilcott 2014-03-31
NCT01922375 Clinical Trial to Evaluate the Efficacy and Safety of Naftopidil in Male Patients With Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT01922375 Completed Dong-A ST Co., Ltd. 2012-09-30
NCT01912339 Safety and Efficacy Study for the Treatment of BPH (Enlarged Prostate) https://ClinicalTrials.gov/show/NCT01912339 Completed Boston Scientific Corporation 2015-03-31
NCT01846793 Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)(NX02-0022) https://ClinicalTrials.gov/show/NCT01846793 Completed Nymox Corporation 2014-10-31
NCT01822288 The Impact of Hormone Therapy on Lower Urinary Tract Symptoms, Sexual Function and Psychosomatic Disorder https://ClinicalTrials.gov/show/NCT01822288 Recruiting Far Eastern Memorial Hospital 2021-12-31
NCT01812928 Diclofenac Suppository to Control Pain During Flexible Cystoscopy https://ClinicalTrials.gov/show/NCT01812928 Completed Aga Khan University 2013-08-31
NCT01726270 An 8-week, Open-label, Uncontrolled Study of Tamsulosin 0.4mg in Men With Bothersome Urinary Symptoms https://ClinicalTrials.gov/show/NCT01726270 Completed Boehringer Ingelheim 2013-03-31
NCT01570673 Group Versus Individual Urotherapy for Children https://ClinicalTrials.gov/show/NCT01570673 Completed Hamilton Health Sciences Corporation 2014-05-31
NCT01457573 Pilot Trial Of Urinary Nerve Growth Factor (NGF) As Biomarker for Male Lower Urinary Tract Symptoms https://ClinicalTrials.gov/show/NCT01457573 Completed The Methodist Hospital System 2014-07-31
NCT01454349 Study of PRX302 for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia (BPH) https://ClinicalTrials.gov/show/NCT01454349 Completed Sophiris Bio Corp 2013-03-31
NCT01381120 Therapeutic Merit of Solifenacin in the Mitigation of Ureteral Stent-induced Pain and Lower Urinary Tract Symptoms https://ClinicalTrials.gov/show/NCT01381120 Completed Barrie Urology Associates 2012-06-30
NCT04391114 Top-Down Holmium Laser Enucleation of the Prostate (HoLEP) vs the Traditional HoLEP for Treatment of Benign Prostatic Hyperplasia (BPH) https://ClinicalTrials.gov/show/NCT04391114 Recruiting Thunder Bay Regional Research Institute 2021-10-15
NCT04386941 Greenlight Vaporization vs Xpeeda Vaporesection https://ClinicalTrials.gov/show/NCT04386941 Recruiting Thunder Bay Regional Research Institute 2022-07-10
NCT04284761 A Study to Establish the Feasibility of Biolen for the Local Delivery of Bicalutamide in Patients With Prostate Cancer https://ClinicalTrials.gov/show/NCT04284761 Recruiting Alessa Therapeutics Inc. 2020-09-30
NCT04198103 Transperineal Laser Ablation for Percutaneous Treatment of Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT04198103 Active, not recruiting University of Rome Tor Vergata 2019-11-01
NCT04102566 Optimizing Pain Control in Transurethral Resection of the Prostate https://ClinicalTrials.gov/show/NCT04102566 Recruiting Benaroya Research Institute 2019-10-01
NCT04044573 Focal Laser Ablation for Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT04044573 Recruiting University of Rome Tor Vergata 2023-04-05
NCT03936244 Bipolar Plasmakinetic TURP Versus Monopolar TURP in the Treatment of Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH) https://ClinicalTrials.gov/show/NCT03936244 Active, not recruiting Hospital Universitario de Fuenlabrada 2017-12-12
NCT03865459 The Effect of Watching Relaxing Video During Cystoscopy https://ClinicalTrials.gov/show/NCT03865459 Completed Saglik Bilimleri Universitesi Gulhane Tip Fakultesi 2018-03-22
NCT03856242 Benign Prostatic Hyperplasia and Ischemic Heart DIsease https://ClinicalTrials.gov/show/NCT03856242 Completed I.M. Sechenov First Moscow State Medical University 2017-09-01
NCT03833752 Flexible V/S Rigid Cystoscopy In Men With Urinary Tract Infection https://ClinicalTrials.gov/show/NCT03833752 Completed Maulana Azad Medical College 2017-12-31
NCT03831321 The Effect of Preemptive Analgesia On The Comfort Of Patient and Doctor, in Cystoscopy https://ClinicalTrials.gov/show/NCT03831321 Recruiting Istanbul Medeniyet University 2019-04-22
NCT03817931 Higher Neural Changes Following Anticholinergic, Beta 3 Agonist, or Placebo in Patients With Overactive Bladder https://ClinicalTrials.gov/show/NCT03817931 Recruiting Baylor Research Institute 2020-05-01
NCT03802851 HoLEP Prior to Radiation Therapy for Patients With LUTS/Retention and Concurrent Prostate Cancer https://ClinicalTrials.gov/show/NCT03802851 Recruiting University of Kansas Medical Center 2030-01-31
NCT03772808 Effects of LycoComfortâ„¢ Supplementation on Symptoms Associated With Lower Urinary Tract Symptoms (LUTS) https://ClinicalTrials.gov/show/NCT03772808 Completed LycoRed Ltd. 2019-04-30
NCT03750656 Use of Hyoscyamine Versus Tamsulosin for Management of Ureteral Stent Irritation https://ClinicalTrials.gov/show/NCT03750656 Recruiting University of Kansas Medical Center 2021-11-30
NCT03729336 PEEZY Midstream Urine Device Compared to Catheterized Urine Sample https://ClinicalTrials.gov/show/NCT03729336 Completed Baylor Research Institute 2019-04-12
NCT03713411 Is Urethral Catheter Necessary After Ureteroscopy and DJ Stent Placement? https://ClinicalTrials.gov/show/NCT03713411 Recruiting Marmara University 2020-04-01
NCT03669692 Open Randomized Clinical Trial to Evaluate the Effects of Intermittent Caloric Restriction in Patients With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia. https://ClinicalTrials.gov/show/NCT03669692 Recruiting Complexo Hospitalario Universitario de A Coruña 2022-12-10
NCT03633994 Heparin Intraoperative Instillation for Lower Urinary Tract Symptoms After Benign Hysterectomy https://ClinicalTrials.gov/show/NCT03633994 Recruiting The Christ Hospital 2019-12-31
NCT03625492 Fluids Affecting Bladder Urgency and Lower Urinary Symptoms https://ClinicalTrials.gov/show/NCT03625492 Completed University of Michigan 2019-09-17
NCT03623880 Enhancing Behavioral Treatment for Women With Pelvic Floor Disorders https://ClinicalTrials.gov/show/NCT03623880 Recruiting Northwestern University 2020-09-30
NCT03605745 Minimally Invasive Prostatic Vapor Ablation for the Treatment of BPH in Large Prostates (Rezūm XL) https://ClinicalTrials.gov/show/NCT03605745 Active, not recruiting Boston Scientific Corporation 2020-09-30
NCT03603015 Contractility: Cuff Versus Urodynamics Testing In Males With Voiding Lower Urinary Tract Symptoms https://ClinicalTrials.gov/show/NCT03603015 Recruiting Newcastle-upon-Tyne Hospitals NHS Trust 2019-03-31
NCT03527589 Embosphere® PROstate Post Market Study https://ClinicalTrials.gov/show/NCT03527589 Active, not recruiting Merit Medical Systems, Inc. 2022-09-01
NCT03524339 Tamsulosin vs Placebo to Prevent Postoperative Urinary Retention in Female Pelvic Reconstructive Surgery https://ClinicalTrials.gov/show/NCT03524339 Completed University Hospitals Cleveland Medical Center 2020-06-09
NCT03450811 Effect of Inguinal Hernia Repair on Uroflowmetric Parameteres https://ClinicalTrials.gov/show/NCT03450811 Completed Ankara Training and Research Hospital 2018-02-20
NCT03434873 Effect of Motor Cortex Versus Sacral Magnetic Stimulation in Multiple Sclerosis Patients With Urinary Tract Dysfunction https://ClinicalTrials.gov/show/NCT03434873 Completed Cairo University 2015-04-30
NCT01260129 Safety and Efficacy of QD Versus BID Silodosin With Lower Urinary Tract Symptoms Suggestive of BPH https://ClinicalTrials.gov/show/NCT01260129 Completed JW Pharmaceutical 2010-11-30
NCT01175382 Combined Behavioral and Drug Treatment of Overactive Bladder in Men https://ClinicalTrials.gov/show/NCT01175382 Completed University of Alabama at Birmingham 2015-07-31
NCT01042249 Pelvic Floor Muscle Training(PFMT) on Lower Urinary Tract Symptoms (LUTS) in Men With Stroke https://ClinicalTrials.gov/show/NCT01042249 Completed Glostrup University Hospital, Copenhagen 2017-04-26
NCT01021332 Long Term Study of Solifenacin Succinate and Tamsulosin Hydrochloride Oral Controlled Absorption System (OCAS) in Males With Lower Urinary Tract Symptoms https://ClinicalTrials.gov/show/NCT01021332 Completed Astellas Pharma Inc 2011-12-14
NCT01018511 Study of Solifenacin Succinate and Tamsulosin Hydrochloride OCAS in Males With Lower Urinary Tract Symptoms https://ClinicalTrials.gov/show/NCT01018511 Completed Astellas Pharma Inc 2011-03-31
NCT01002664 Efficacy and Safety of MCS-2 in the Treatment of Lower Urinary Tract Symptoms https://ClinicalTrials.gov/show/NCT01002664 Completed Health Ever Bio-Tech Co., Ltd. 2014-06-30
NCT01002417 MCS in the Treatment of Lower Urinary Tract Symptoms https://ClinicalTrials.gov/show/NCT01002417 Completed Health Ever Bio-Tech Co., Ltd. 2014-02-28
NCT01002274 Open-Label Extension Study of MCS-2 in the Treatment of Lower Urinary Tract Symptoms https://ClinicalTrials.gov/show/NCT01002274 Completed Health Ever Bio-Tech Co., Ltd. 2014-06-30
NCT01002222 Open-Label Extension Study of MCS-2 in the Treatment of Lower Urinary Tract Symptoms (MCS-2-US-c) https://ClinicalTrials.gov/show/NCT01002222 Completed Health Ever Bio-Tech Co., Ltd. 2014-02-28
NCT00947882 A Trial of Degarelix in Men With Lower Urinary Tract Symptoms (LUTS) Associated With Benign Prostatic Hyperplasia (BPH) https://ClinicalTrials.gov/show/NCT00947882 Completed Ferring Pharmaceuticals 2011-03-31
NCT00939120 Dutasteride With Tolterodine ER or Placebo to Treat Lower Urinary Tract Symptoms (LUTS) https://ClinicalTrials.gov/show/NCT00939120 Completed Siami, Paul F., M.D. 2014-09-30
NCT00918034 Study of Light-Activated Talaporfin Sodium in Patients With Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH) https://ClinicalTrials.gov/show/NCT00918034 Completed Light Sciences Oncology 2011-02-28
NCT00908427 Impact of 80 W KTP Laser Vaporization Prostatectomy on Severity of Obstruction in Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT00908427 Completed Samsung Medical Center 2006-05-31
NCT00893113 An Efficacy Study to Evaluate Alfuzosin to Treat Men With Erectile Dysfunction and Mild Lower Urinary Tract Symptoms https://ClinicalTrials.gov/show/NCT00893113 Completed Chesapeake Urology Research Associates 2012-10-31
NCT00877669 Efficacy Study of HoLEP and TURP on LUTS Secondary to BPH https://ClinicalTrials.gov/show/NCT00877669 Completed Samsung Medical Center 2016-07-31
NCT04418635 Herbal Supplement Prosta-OK® Neo as an Adjunct Therapy in Patients With Mild to Severe Non-neurogenic Male Lower Urinary Tract Symptoms Receiving Tamsulosin Therapy https://ClinicalTrials.gov/show/NCT04418635 Recruiting Acrobio Healthcare Inc. 2021-12-31
NCT03055624 Prostate Artery Embolization for the Treatment of Symptomatic Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT03055624 Completed University of California, San Diego 2019-02-18
NCT00836823 Evaluation of Symptom-specific Goal Achievement https://ClinicalTrials.gov/show/NCT00836823 Completed Samsung Medical Center 2008-08-31
NCT03625843 Mindfulness Exercises to Reduce Anxiety and Pain During Urodynamic Testing https://ClinicalTrials.gov/show/NCT03625843 Completed San Antonio Uniformed Services Health Education Consortium 2017-12-30
NCT01966614 Randomized, Double-Blind, Vehicle-Controlled, Multicenter Safety and Efficacy Study of Intraprostatic PRX302 for LUTS BPH https://ClinicalTrials.gov/show/NCT01966614 Completed Sophiris Bio Corp 2015-12-31
NCT02856217 Impact of Tunneling During Minimally Invasive Sacrocolpopexy https://ClinicalTrials.gov/show/NCT02856217 Completed The University of Texas Medical Branch, Galveston 2017-09-30
NCT02180789 A Study to Evaluate the Tolerability and Efficacy of Tamsulosin 0.4mg OCAS Formulation in Patients Who Are Unsatisfied With the Treatment of Tamsulosin 0.2mg Conventional Formulation https://ClinicalTrials.gov/show/NCT02180789 Completed Astellas Pharma Inc 2015-01-31
NCT03520166 Use of Medium Frequency Electrotherapy in the Treatment of OAB, LUTS and Pelvic Pain https://ClinicalTrials.gov/show/NCT03520166 Completed Fisioterapia Pélvica Avanzada Madrid, SRL 2017-06-15
NCT00710749 The Value of Multiple Urine Flow Rate Measurements in Male Benign Prostatic Hyperplasia (BPH) Subjects https://ClinicalTrials.gov/show/NCT00710749 Completed Wellspect HealthCare 2009-04-30
NCT00709488 Phase 1 Study of the Litxâ„¢ BPH System in Patients With Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH) https://ClinicalTrials.gov/show/NCT00709488 Completed Light Sciences Oncology 2011-04-30
NCT00706407 Uro-NIRS Clinical Study https://ClinicalTrials.gov/show/NCT00706407 Completed Weill Medical College of Cornell University 2010-05-31
NCT00693199 Effect of Amlodipine Monotherapy or Combined With Terazosin on Lower Urinary Tract Symptoms and Hypertension https://ClinicalTrials.gov/show/NCT00693199 Completed Anhui Medical University 2006-10-31
NCT00575913 Alfuzosin XL Lower Urinary Tract Symptoms Efficacy and Sexuality Study https://ClinicalTrials.gov/show/NCT00575913 Completed Sanofi NA
NCT00510406 A Study With Combination Treatment (Tamsulosin Hydrochloride and Solifenacin Succinate) in Male Patients With LUTS/BPH https://ClinicalTrials.gov/show/NCT00510406 Completed Astellas Pharma Inc 2007-09-30
NCT00507455 Solifenacin Succinate With Tamsulosin HCl in Males With Lower Urinary Tract Symptoms and Bladder Outlet Obstruction https://ClinicalTrials.gov/show/NCT00507455 Completed Astellas Pharma Inc 2008-08-31
NCT00457457 Study the Effects of Different Doses of UK-369,003 in Men With Lower Urinary Tract Symptoms. https://ClinicalTrials.gov/show/NCT00457457 Completed Pfizer 2008-04-30
NCT00427219 The Safety and Efficacy of Ozarelix to Treat Men With Lower Urinary Tract Symptoms Due to Enlargement of the Prostate https://ClinicalTrials.gov/show/NCT00427219 Completed Spectrum Pharmaceuticals, Inc 2008-04-30
NCT00410514 A Study of Mirabegron (YM178) in Men With Lower Urinary Tract Symptoms (LUTS) and Bladder Outlet Obstruction (BOO) https://ClinicalTrials.gov/show/NCT00410514 Completed Astellas Pharma Inc 2008-08-31
NCT00409357 Dose Ranging Study of Alfuzosin in Patients With Lower Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia https://ClinicalTrials.gov/show/NCT00409357 Completed Sanofi 2005-08-31
NCT00408954 Urodynamic Effects of UK-369,003 in Men With Lower Urinary Tract Symptoms https://ClinicalTrials.gov/show/NCT00408954 Completed Pfizer 2008-06-30
NCT00338624 An Effectiveness and Safety Study Comparing Oxybutynin Chloride Plus FLOMAX (Tamsulosin HCl) and Placebo Plus FLOMAX (Tamsulosin HCl) for the Treatment of Lower Urinary Tract Symptoms. https://ClinicalTrials.gov/show/NCT00338624 Completed McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. NA
NCT00270309 Self-management for Men With Uncomplicated Lower Urinary Tract Symptoms https://ClinicalTrials.gov/show/NCT00270309 Completed The Royal College of Surgeons of England 2004-04-30
NCT00111592 Effectiveness of a Treatment Protocol for Lower Urinary Tract Symptoms in General Practice https://ClinicalTrials.gov/show/NCT00111592 Completed Maastricht University Medical Center NA
NCT00540891 The Efficacy, Onset of Effect, and Safety of Alfuzosin Once Daily in the Treatment of Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia: A Randomized, Placebo-Controlled Trial Using an Acute International Prostate Score https://ClinicalTrials.gov/show/NCT00540891 Completed Sanofi NA

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT03394651 Prostatic Obstruction Investigation Team Multicenter Study https://ClinicalTrials.gov/show/NCT03394651 Recruiting Changhai Hospital 2019-04-01
NCT03339609 Uroflow Measurement With Electromyography (EMG) to Identify Lower Urinary Tract Symptoms (LUTS): Conducted on Healthy Children https://ClinicalTrials.gov/show/NCT03339609 Completed University Hospital, Ghent 2017-05-31
NCT03317340 Environmental Factors to Increase Patient Comfort During Urodynamics Testing https://ClinicalTrials.gov/show/NCT03317340 Enrolling by invitation Mayo Clinic 2020-08-31
NCT03314610 Effect of Need to Void on Parkinsonian Gait https://ClinicalTrials.gov/show/NCT03314610 Completed Pierre and Marie Curie University 2017-12-28
NCT03272386 Best Verbal Instruction to Obtain Voluntary Pelvic Floor Muscle Contraction https://ClinicalTrials.gov/show/NCT03272386 Completed Pierre and Marie Curie University 2017-09-18
NCT03255421 Filling and Emptying Cystometries (“Backwards Cystometry”): a Feasibility and Validation Study https://ClinicalTrials.gov/show/NCT03255421 Completed Pierre and Marie Curie University 2017-08-28
NCT03228485 Benign Prostatic Hyperplasia (BPH) Mobile Application Pilot Study https://ClinicalTrials.gov/show/NCT03228485 Recruiting Société Internationale d’Urologie 2021-04-10
NCT03204747 Effect of Need to Void on Gait Speed in Multiple Sclerosis https://ClinicalTrials.gov/show/NCT03204747 Completed Pierre and Marie Curie University 2017-08-31
NCT03174600 Impact of Lower Urinary Tract Dysfunction on Clinical Manifestation in Patients With Stroke https://ClinicalTrials.gov/show/NCT03174600 Completed Ege University 2017-02-01
NCT03033355 Central Nervous System Changes Following BotulinumtoxinA Injection in the Bladder https://ClinicalTrials.gov/show/NCT03033355 Completed The Methodist Hospital System 2019-03-31
NCT02623244 The Association Between Ovarian Endometrioma and Lower Urinary Tract Symptoms https://ClinicalTrials.gov/show/NCT02623244 Recruiting Far Eastern Memorial Hospital 2020-09-30
NCT02618421 A Cross-sectional Internet Survey to Estimate Prevalence of Lower Urinary Tract Symptoms (LUTS) https://ClinicalTrials.gov/show/NCT02618421 Completed Astellas Pharma Inc 2015-07-20
NCT02542501 Study to Evaluate the Presence of Lower Urinary Tract Symptoms (LUTS) in Prostate Cancer Patients Scheduled to Receive Luteinizing Hormone Releasing Hormone (LHRH) Analogues https://ClinicalTrials.gov/show/NCT02542501 Completed Ipsen 2018-07-21
NCT02495311 The Association Between Adenomyosis/Uterine Myoma and Lower Urinary Tract Symptoms https://ClinicalTrials.gov/show/NCT02495311 Recruiting Far Eastern Memorial Hospital 2020-12-31
NCT02410135 Myrbetriqâ„¢ (Mirabegron) to Improve Disordered Sleep in Subjects With Lower Urinary Tract Symptoms (LUTS) https://ClinicalTrials.gov/show/NCT02410135 Completed Southern Illinois University 2018-12-31
NCT02245542 The Impact of Alna® Ocas® on Nocturia in Patients With Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH) https://ClinicalTrials.gov/show/NCT02245542 Completed Boehringer Ingelheim 2006-02-28
NCT02060136 Electronic Method for Recording Lower Urinary Tract Symptoms https://ClinicalTrials.gov/show/NCT02060136 Completed University Hospital Ostrava 2014-01-31
NCT01277029 Study of Psychiatric Aspects in Women With Lower Urinary Tract Symptoms https://ClinicalTrials.gov/show/NCT01277029 Recruiting Far Eastern Memorial Hospital 2022-12-31
NCT01738464 Microbiomes of Pelvic Pain https://ClinicalTrials.gov/show/NCT01738464 Recruiting Northwestern University 2021-03-07
NCT01730300 Genitourinary Symptoms With Levonorgestrel Releasing Intrauterine Systems https://ClinicalTrials.gov/show/NCT01730300 Completed Bakirkoy Dr. Sadi Konuk Research and Training Hospital 2013-01-31
NCT01639794 Vesitirimâ„¢ in Men Postmarketing Observational Study https://ClinicalTrials.gov/show/NCT01639794 Completed Astellas Pharma Inc 2012-12-31
NCT01616810 Lower Urinary Tract Symptoms Screening Questionnaire https://ClinicalTrials.gov/show/NCT01616810 Completed St. Michael’s Hospital, Toronto 2007-10-31
NCT01604148 Retrospective Review a Comprehensive Case Database of HoLEP Procedure Performed by a Single Surgeon https://ClinicalTrials.gov/show/NCT01604148 Completed Samsung Medical Center 2011-07-31
NCT01590576 Population-based Estimates of Medical Comorbidities in Women With Lower Urinary Tract Symptoms or Pelvic Organ Prolapse https://ClinicalTrials.gov/show/NCT01590576 Completed Far Eastern Memorial Hospital 2016-01-31
NCT04416152 Impact of Female Pelvic Reconstruction Surgery on Lower Urinary Tract Symptoms, Psychosomatic Distress and Sexual Function https://ClinicalTrials.gov/show/NCT04416152 Recruiting Far Eastern Memorial Hospital 2023-12-31
NCT04383093 Tadalafil Plus Tamsulosin for Male LUTS and ED https://ClinicalTrials.gov/show/NCT04383093 Completed University of Florence 2018-01-01
NCT04124874 Prevalence and Impact on Quality of Life of Lower Urinary Tract Symptoms (LUTS) in Night Workers https://ClinicalTrials.gov/show/NCT04124874 Active, not recruiting Jagiellonian University 2019-12-31
NCT04121936 The Prevalence of Lower Urinary Tract Symptoms (LUTS) in Poland https://ClinicalTrials.gov/show/NCT04121936 Active, not recruiting Jagiellonian University 2019-12-31
NCT04104100 Prevalence and Risk Factor of NP in Women With LUTS https://ClinicalTrials.gov/show/NCT04104100 Completed National Taiwan University Hospital 2019-01-31
NCT04095871 Determinants, Impact and Adherence Related to the Duration of Performing Self Catheterization on Patient Satisfaction and Quality of Life https://ClinicalTrials.gov/show/NCT04095871 Recruiting Pierre and Marie Curie University 2019-10-30
NCT04063852 PTNS on Urinary and Global Quality of Life in MS Patients https://ClinicalTrials.gov/show/NCT04063852 Recruiting University of Michigan 2021-12-31
NCT04016298 Validation of Bladder Health Instrument for Evaluation in Women https://ClinicalTrials.gov/show/NCT04016298 Recruiting University of Minnesota 2020-08-31
NCT03991429 Brain Imaging in Men With Lower Urinary Tract Symptoms https://ClinicalTrials.gov/show/NCT03991429 Enrolling by invitation The Methodist Hospital System 2021-04-01
NCT03808038 Symptoms of Lower Urinary Tract Dysfunction Protocol 2/Recall Study https://ClinicalTrials.gov/show/NCT03808038 Completed Arbor Research Collaborative for Health 2018-05-31
NCT03613350 Prevalence Rates of USI, BO, DO and Their Clinical and Urodynamic Findings in Women With ≥Stage II Cystocele https://ClinicalTrials.gov/show/NCT03613350 Completed National Taiwan University Hospital 2017-01-31
NCT03574298 Effect of Radical Prostatectomy on Involuntary Pelvic Floor Muscle Contraction https://ClinicalTrials.gov/show/NCT03574298 Completed Pierre and Marie Curie University 2018-06-30
NCT03451175 Reproductibility of Cystometry in Multiple Sclerosis Patient https://ClinicalTrials.gov/show/NCT03451175 Completed Pierre and Marie Curie University 2017-11-01
NCT01078545 Lucrin® Depot Efficacy and Safety Monitoring Study in Patients With Advanced Prostate Cancer and Lower Urinary Tract Symptoms (LUTS) https://ClinicalTrials.gov/show/NCT01078545 Completed Abbott 2010-11-30
NCT04338646 Is the Severity of Urinary Disorders Related to Falls in People With Multiple Sclerosis https://ClinicalTrials.gov/show/NCT04338646 Recruiting Pierre and Marie Curie University 2020-04-15
NCT02485808 Symptoms of Lower Urinary Tract Dysfunction Phenotyping Study https://ClinicalTrials.gov/show/NCT02485808 Completed Arbor Research Collaborative for Health 2018-04-30
NCT00667550 Lower Urinary Tract and Sexual Function in Women Following Surgery for Colorectal Disorders https://ClinicalTrials.gov/show/NCT00667550 Completed University of California, Irvine 2010-03-31

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT02434575 UK ROPE Register Study https://ClinicalTrials.gov/show/NCT02434575 Completed Cardiff and Vale University Health Board 2016-12-31
NCT01884753 Correlations of 3D Urethral and Paraurethral Sonographic Findings With Urodynamic Studies, Lower Urinary Tract Symptoms & Sexual Dysfunction in Female Patients With Lower Urinary Tract Symptoms. https://ClinicalTrials.gov/show/NCT01884753 Recruiting Far Eastern Memorial Hospital 2020-12-31
NCT04405141 Uroflowmetry Results and Vitamin D Levels https://ClinicalTrials.gov/show/NCT04405141 Completed Umraniye Education and Research Hospital 2017-12-30
NCT03603821 Comparison of Self-administered IPSS, Sanitary Staff-supervised IPSS, Medical History and Clinical Parameters https://ClinicalTrials.gov/show/NCT03603821 Recruiting Corporacion Parc Tauli 2019-08-01
NCT03521648 Database for the Assessment of Efficacy and Safety of BPH Treatment https://ClinicalTrials.gov/show/NCT03521648 Recruiting Cantonal Hospital of St. Gallen 2027-12-01